Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Harsimar B. Kaur"'
Autor:
Hasim Bakbak, Erolcan Sayar, Harsimar B. Kaur, Daniela C. Salles, Radhika A. Patel, Jessica Hicks, Tamara L. Lotan, Angelo M. De Marzo, Roman Gulati, Jonathan I. Epstein, Michael C. Haffner
Publikováno v:
Human Pathology. 130:18-24
Genomic studies have demonstrated a high level of intra-tumoral heterogeneity in prostate cancer. There is strong evidence suggesting that individual tumor foci can arise as genetically distinct, clonally independent lesions. However, recent studies
Autor:
Adrianna A. Mendes, Jiayun Lu, Harsimar B. Kaur, Siqun L. Zheng, Jianfeng Xu, Jessica Hicks, Adam B. Weiner, Edward M. Schaeffer, Ashley E. Ross, Steven P. Balk, Mary‐Ellen Taplin, Nathan A. Lack, Emirhan Tekoglu, Janielle P. Maynard, Angelo M. De Marzo, Emmanuel S. Antonarakis, Karen S. Sfanos, Corinne E. Joshu, Eugene Shenderov, Tamara L. Lotan
Publikováno v:
Cancer
Background: B7 homolog 3 (B7-H3) is an immunomodulatory molecule that is highly expressed in prostate cancer (PCa) and belongs to the B7 superfamily, which includes PD-L1. Immunotherapies (antibodies, antibody-drug conjugates, and chimeric antigen re
Autor:
Harsimar B. Kaur, Kirsten Timms, Sanjana Murali, Edward M. Schaeffer, Daniela C. Salles, Olivier Cussenot, Robert S. Brown, Geraldine Cancel-Tassin, William B. Isaacs, Emmanuel S. Antonarakis, Tamara L. Lotan, Jerry S. Lanchbury, Andrea L. Richardson
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
The homologous recombination deficiency (HRD) score integrates three DNA-based measures of genomic instability, and has been understudied in prostate cancer. Given the recent FDA approval of two PARP inhibitors for prostate cancer, HRD score analysis
Autor:
Tamara L. Lotan, Harsimar B. Kaur, Jonathan I. Epstein, James R. Eshleman, Adina Paulk, Daniela C. Salles
Publikováno v:
Histopathology
AIMS Prostatic intraepithelial neoplasia-like (PIN-like) ductal carcinoma is a rare tumour characterised by often cystically dilated glands architecturally resembling high-grade PIN, but lacking basal cells. These tumours are frequently accompanied b
Autor:
Kirsten Timms, Emmanuel S. Antonarakis, Jessica Hicks, Colin C. Pritchard, Bruce J. Trock, Angelo M. De Marzo, Tamara L. Lotan, Daniela C. Salles, Harsimar B. Kaur, William B. Isaacs, Minh Nguyen, Jerry S. Lanchbury, Sanjana Murali
Publikováno v:
Clinical Cancer Research. 26:4869-4881
Purpose:The ATM (ataxia telangiectasia mutated) gene is mutated in a subset of prostate cancers, and ATM mutation may confer specific therapeutic vulnerabilities, although ATM-deficient prostate cancers have not been well-characterized.Experimental D
Autor:
Iryna Samarska, Jonathan I. Epstein, Tamara L. Lotan, Harsimar B. Kaur, Mohamed Alshalalfa, Edward M. Schaeffer, Sanjana Murali, Jiayun Lu, Benjamin L. Maughan, Emmanuel S. Antonarakis, Corinne E. Joshu, Juan Miguel Mosquera, Farzana A. Faisal, Kaushal Asrani
Publikováno v:
Prostate
BACKGROUND Small cell neuroendocrine (NE) carcinomas of the prostate classically lose androgen receptor (AR) expression, may harbor loss of the RB1, TP53, and PTEN tumor suppressor genes, and are associated with a poor prognosis. However usual-type a
Autor:
Thiago Vidotto, Harsimar B. Kaur, Daniela C. Salles, Emmanuel S. Antonarakis, William B. Isaacs, Tamara L. Lotan, Adrianna A. Mendes
Publikováno v:
Cancer Immunol Immunother
Pathogenic mutations in homologous recombination (HR) DNA repair genes may be associated with increased tumor mutational burden and numbers of tumor-infiltrating lymphocytes (TIL). Though HR-deficient prostate tumors have been anecdotally associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb4d722df3c005707de7ce11187926c7
https://europepmc.org/articles/PMC9254167/
https://europepmc.org/articles/PMC9254167/
Autor:
Tamara L. Lotan, John R. Barber, Edward M. Schaeffer, Laneisha Maldonado, Angelo M. De Marzo, Corinne E. Joshu, Liana B. Guedes, Mario A. Eisenberger, Jiayun Lu, Harsimar B. Kaur, Scott A. Tomlins, Karen S. Sfanos, Logan Reitz
Publikováno v:
Hum Pathol
Summary The makeup of the tumor immune microenvironment may be associated with tumor somatic genomic alterations and plays a key role in tumor progression and response to immunotherapy. We examined the association of tumor-infiltrating T-cell density
Autor:
Abdullah M Alharbi, Harsimar B. Kaur, Tamara L. Lotan, Colin C. Pritchard, Jonathan I. Epstein
Publikováno v:
Histopathology
Aims Prostatic adenocarcinomas with focal pleomorphic giant-cell features constitute a rare tumour subtype with abysmal clinical outcomes. More than one-third of patients with this histology die within a year of the initial diagnosis of prostate canc
Autor:
Jeffrey J. Tosoian, Farzana A. Faisal, Tamara L. Lotan, Harsimar B. Kaur, Scott A. Tomlins, Edward M. Schaeffer
Publikováno v:
Prostate Cancer and Prostatic Diseases. 22:552-559
The SPINK1 molecular subtype is more common in African-American (AA) men with prostatic adenocarcinoma (PCa) than European Americans (EA). Studies have suggested that SPINK1 expression is associated with more aggressive disease. However, the size, fo